First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE

First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE

Abstract Background ENCORE, an observational, prospective, open‐label study, investigated real‐world treatment practices and outcomes with cetuximab plus platinum‐based therapy (PBT) in first‐line (1L) recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). Aims This mu...

Full description

Bibliographic Details
Main Authors: Christophe Le Tourneau, Massimo Ghiani, Maria Chiara Cau, Roberta Depenni, Graziana Ronzino, Pierluigi Bonomo, Vincenzo Montesarchio, Luigi Leo, Jeltje Schulten, Satu Salmio, Diethelm Messinger, Andrea Sbrana, Edith Borcoman, Maria Grazia Ghi
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Cancer Reports
Subjects:
cetuximab
combination chemotherapy
first‐line
observational study
squamous cell carcinoma of head and neck
Online Access:https://doi.org/10.1002/cnr2.1804

Internet

https://doi.org/10.1002/cnr2.1804

Similar Items